Calhoun ES - Search Results

1

Targeted deletion of MKK4 in cancer cells: a detrimental phenotype manifests as decreased experimental metastasis and suggests a counterweight to the evolution of tumor-suppressor loss.

Cunningham SC, Gallmeier E, Hucl T, Dezentje DA, Calhoun ES, Falco G, Abdelmohsen K, Gorospe M, Kern SE. Cunningham SC, et al. Among authors: calhoun es. Cancer Res. 2006 Jun 1;66(11):5560-4. doi: 10.1158/0008-5472.CAN-06-0555. Cancer Res. 2006. PMID: 16740690

2

Identifying allelic loss and homozygous deletions in pancreatic cancer without matched normals using high-density single-nucleotide polymorphism arrays.

Calhoun ES, Hucl T, Gallmeier E, West KM, Arking DE, Maitra A, Iacobuzio-Donahue CA, Chakravarti A, Hruban RH, Kern SE. Calhoun ES, et al. Cancer Res. 2006 Aug 15;66(16):7920-8. doi: 10.1158/0008-5472.CAN-06-0721. Cancer Res. 2006. PMID: 16912165

3

Gene-specific selection against experimental fanconi anemia gene inactivation in human cancer.

Gallmeier E, Hucl T, Calhoun ES, Cunningham SC, Bunz F, Brody JR, Kern SE. Gallmeier E, et al. Among authors: calhoun es. Cancer Biol Ther. 2007 May;6(5):654-60. doi: 10.4161/cbt.6.5.3978. Epub 2007 Feb 7. Cancer Biol Ther. 2007. PMID: 17387268 Free article.

4

Targeted disruption of FANCC and FANCG in human cancer provides a preclinical model for specific therapeutic options.

Gallmeier E, Calhoun ES, Rago C, Brody JR, Cunningham SC, Hucl T, Gorospe M, Kohli M, Lengauer C, Kern SE. Gallmeier E, et al. Among authors: calhoun es. Gastroenterology. 2006 Jun;130(7):2145-54. doi: 10.1053/j.gastro.2006.03.016. Gastroenterology. 2006. PMID: 16762635

5

A double missense variation of the BUB1 gene and a defective mitotic spindle checkpoint in the pancreatic cancer cell line Hs766T.

Hempen PM, Kurpad H, Calhoun ES, Abraham S, Kern SE. Hempen PM, et al. Among authors: calhoun es. Hum Mutat. 2003 Apr;21(4):445. doi: 10.1002/humu.9120. Hum Mutat. 2003. PMID: 12655561

6

Copy-number methods dramatically underestimate loss of heterozygosity in cancer.

Calhoun ES, Gallmeier E, Cunningham SC, Eshleman JR, Hruban RH, Kern SE. Calhoun ES, et al. Genes Chromosomes Cancer. 2006 Nov;45(11):1070-1. doi: 10.1002/gcc.20365. Genes Chromosomes Cancer. 2006. PMID: 16897743 No abstract available.

7

FAM190A rearrangements provide a multitude of individualized tumor signatures and neo-antigens in cancer.

Scrimieri F, Calhoun ES, Patel K, Gupta R, Huso DL, Hruban RH, Kern SE. Scrimieri F, et al. Among authors: calhoun es. Oncotarget. 2011 Jan-Feb;2(1-2):69-75. doi: 10.18632/oncotarget.220. Oncotarget. 2011. PMID: 21378412 Free PMC article.

8

Ultra-fast high-resolution agarose electrophoresis of DNA and RNA using low-molarity conductive media.

Brody JR, Calhoun ES, Gallmeier E, Creavalle TD, Kern SE. Brody JR, et al. Among authors: calhoun es. Biotechniques. 2004 Oct;37(4):598, 600, 602. doi: 10.2144/04374ST04. Biotechniques. 2004. PMID: 15517972 Free article.

9

BRAF and FBXW7 (CDC4, FBW7, AGO, SEL10) mutations in distinct subsets of pancreatic cancer: potential therapeutic targets.

Calhoun ES, Jones JB, Ashfaq R, Adsay V, Baker SJ, Valentine V, Hempen PM, Hilgers W, Yeo CJ, Hruban RH, Kern SE. Calhoun ES, et al. Am J Pathol. 2003 Oct;163(4):1255-60. doi: 10.1016/S0002-9440(10)63485-2. Am J Pathol. 2003. PMID: 14507635 Free PMC article.

10

Somatic mutations of GUCY2F, EPHA3, and NTRK3 in human cancers.

Wood LD, Calhoun ES, Silliman N, Ptak J, Szabo S, Powell SM, Riggins GJ, Wang TL, Yan H, Gazdar A, Kern SE, Pennacchio L, Kinzler KW, Vogelstein B, Velculescu VE. Wood LD, et al. Among authors: calhoun es. Hum Mutat. 2006 Oct;27(10):1060-1. doi: 10.1002/humu.9452. Hum Mutat. 2006. PMID: 16941478

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters